DEXMETHYLPHENIDATE HYDROCHLORIDE
DEXMETHYLPHENIDATE HYDROCHLORIDE
Approval overview DEXMETHYLPHENIDATE HYDROCHLORIDE is listed in Drugs@FDA under application 215523 (ANDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient DEXMETHYLPHENIDATE HYDROCHLORIDE Form and strength CAPSULE, EXTENDED RELEASE;ORAL - 30MG Sponsor ASCENT PHARMS INC Submission history Latest submission status date: 2025-01-15 00:00:00.
Structured Monograph
Clinical summary
Approval overview DEXMETHYLPHENIDATE HYDROCHLORIDE is listed in Drugs@FDA under application 215523 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient DEXMETHYLPHENIDATE HYDROCHLORIDE Form and strength CAPSULE, EXTENDED RELEASE;ORAL - 30MG Sponsor ASCENT PHARMS INC Submission history Latest submission status date: 2025-01-15 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.